Ascorbic acid clearance in diabetic nephropathy

Journal of Diabetes and its Complications

Volumn 12, Issue 5, 1998, Pages 259-263

  Hirsch, Irl B ^a   Atchley, Daniel H ^b   Tsai, Elaine ^a   Labbé, Robert F ^b   Chait, Alan ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Nutrition   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIOXIDANT; ASCORBIC ACID;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; FEMALE; GLUCOSE URINE LEVEL; HUMAN; KIDNEY CLEARANCE; KIDNEY FUNCTION; MALE; MICROALBUMINURIA; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEINURIA; URINE LEVEL;

ADULT; ALBUMINURIA; ASCORBIC ACID; ASCORBIC ACID DEFICIENCY; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED;

EID: 0031684259     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(97)00125-6     Document Type: Article

References (29)

1. Nelson RG, Knowler W, Pettitt DJM, et al.: Kidney disease in diabetes. Diabetes in America, 2nd edition. pp. 249-285, 1995.
2. Borch-Johnsen K., Kreiner S. Proteinuria. Value as predictor of cardiovascular mortality in insulin-dependent diabetes BMJ. 294:1987;1651-1654.
3. Krolewski A.S., Kosinski E.J., Warram J.H., Lelund O.S., Busick E.J., Asmal A.C., Rand L.I., Christlieb A.R., Bradley R.F., Kahn C.R. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin dependent diabetes mellitus. Am J Cardiol. 59:1987;750-755.
4. Lemmers M.J., Barry J.M. Major role for arterial disease in morbidity and mortality after kidney transplantation in diabetic recipients. Diabetes Care. 14:1991;295-301.
5. Parving H.H., Gall M.A., Nielsen F.S. Dyslipidemia and cardiovascular disease in non-insulin-dependent diabetic patients with and without diabetic nephropathy. J Intern Med Suppl. 736:1994;89-94.
6. Mattock M.B., Morrish N.J., Viberti G.et al. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes. 41:1992;736-741.
7. Bierman E.L. Atherogenesis in diabetes. Artrioscler Thromb. 12:1992;647-656.
8. Witztum J.L. The oxidation hypothesis of atherosclerosis. Lancet. 344:1994;793-795.
9. Wolff S.P., Jiang Z.Y., Hunt J.V. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic Biol Med. 10:1991;339-352.
10. Baynes J.W. Role of oxidative stress in the development of complications in diabetes. Diabetes. 40:1991;405-412.
11. Tsai E.C., Hirsch I.B., Brunzell J.D.et al. Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes. 43:1994;1010-1014.
12. Sies H., Stahl W., Sundquist A.R. Antioxidant functions of vitamins. Vitamins E and C, beta-carotene, and other carotenoids Ann NY Acad Sci. 669:1992;7-20.
13. Frei B, England L, Ames BN: Proc Natl Acad Sci USA 86:6377-6381, 1989.
14. Jialal I., Grundy S.M. Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification. J Clin Invest. 87:1991;597-601.
15. Wartanowicz M., Panczenko-Kresowska B., Ziemlanski S.et al. The effect of alpha-tocopheral and ascorbic acid on the serum lipid peroxide level in elderly people. Ann Nutr Metab. 28:1984;186-191.
16. Sinclair A.J., Taylor P.B., Lunec J.et al. Low plasma ascorbate in patients with type 2 diabetes mellitus consuming adequate dietary vitamin C. Diabetic Med. 11:1994;893-898.
17. Sinclair A.J., Girling A.J., Gray L.et al. Disturbed handling of ascorbic acid in diabetic patients with and without microangiopathy during high dose ascorbate supplementation. Diabetologia. 34:1991;171-175.
18. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron. 16:1976;31-41.
19. Little R.R., Wiedmeyer H.M., England J.D.et al. Interlaboratory standardization of measurements of glycohemoglobin. Clin Chem. 38:1992;2472-2478.
20. Tully R.T. New enzymatic method for the analysis of vitamin C in plasma and automation on the Beckman CS5. Clin Chem. 38:1992;1070.
21. Nagano S., Kurokawa M., Ebara T.et al. Decreases of serum ascorbic acid concentrations in patients with diabetic macroangiopathy. J Nutr Sci Vitaminol (Tokyo). 42:1996;1-9.
22. Yue D.K., McLennan S., McGill M.et al. Abnormalities of ascorbic acid metabolism and diabetic control. Differences between diabetic patients and diabetic rats Diabetes Res Clin Pract. 9:1990;239-244.
23. Majumder P.K., Banerjee S.K., Roy R.K., Chatterjee G.C. Effect of insulin on the metabolism of l-ascorbic acid in animals. Biochem Pharmacol. 22:1973;759-761.
24. Seghieri G., Martinoli L., Miceli M.et al. Renal excretion of ascorbic acid in insulin dependent diabetes mellitus. Int J Vitam Nutr Res. 64:1994;119-124.
25. Kallner A., Hartmann D., Hornig D. Steady-state turnover and body poor of ascorbic acid in man. Am J Clin Nutr. 32:1979;530-539.
26. Hepstinstall R.D. Pathology of the Kidney. 3:1983;Little, Brown, Boston. 1397.
27. Abrass K.C. Diabetic proteinuria. Glomerular or tubular in origin? Am J Nephrol. 4:1984;337-346.
28. Nyyssönen K., Parviainen M.T., Salonen R.et al. Vitamin C deficiency and risk of myocardial infarction. Prospective population study of men from eastern Finland BMJ. 314:1997;634-638.
29. McLennan S., Yue D.K., Fisher E.et al. Deficiency of ascorbic acid in experimental diabetes. Diabetes. 37:1988;359-361.